Eudaimonia Partners LLC Has $237,000 Holdings in Colgate-Palmolive (NYSE:CL)

Posted by Defense World Staff on Apr 3rd, 2023

Eudaimonia Partners LLC trimmed its stake in Colgate-Palmolive (NYSE:CL – Get Rating) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,010 shares of the company’s stock after selling 194 shares during the period. Eudaimonia Partners LLC’s holdings in Colgate-Palmolive were worth $237,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Equitable Holdings Inc. raised its position in shares of Colgate-Palmolive by 1.7% in the third quarter. Equitable Holdings Inc. now owns 7,780 shares of the company’s stock valued at $547,000 after buying an additional 133 shares during the last quarter. Lumature Wealth Partners LLC lifted its stake in Colgate-Palmolive by 3.3% in the third quarter. Lumature Wealth Partners LLC now owns 4,199 shares of the company’s stock worth $295,000 after acquiring an additional 135 shares during the last quarter. Stratos Wealth Advisors LLC raised its holdings in Colgate-Palmolive by 1.7% during the fourth quarter. Stratos Wealth Advisors LLC now owns 8,273 shares of the company’s stock worth $652,000 after purchasing an additional 137 shares in the last quarter. Nicholas Hoffman & Company LLC. raised its holdings in Colgate-Palmolive by 0.9% during the third quarter. Nicholas Hoffman & Company LLC. now owns 15,913 shares of the company’s stock worth $1,118,000 after purchasing an additional 141 shares in the last quarter. Finally, East Coast Asset Management LLC. raised its holdings in Colgate-Palmolive by 0.6% during the third quarter. East Coast Asset Management LLC. now owns 22,376 shares of the company’s stock worth $1,572,000 after purchasing an additional 142 shares in the last quarter. 77.63% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL opened at $75.15 on Monday. The stock has a market cap of $62.40 billion, a PE ratio of 35.28, a P/E/G ratio of 3.91 and a beta of 0.48. The company has a current ratio of 1.28, a quick ratio of 0.76 and a debt-to-equity ratio of 10.84. Colgate-Palmolive has a 1 year low of $67.84 and a 1 year high of $83.81. The stock’s 50 day simple moving average is $73.47 and its 200-day simple moving average is $74.73.

Colgate-Palmolive (NYSE:CL – Get Rating) last issued its quarterly earnings results on Friday, January 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Colgate-Palmolive had a return on equity of 317.08% and a net margin of 9.93%. The business had revenue of $4.63 billion for the quarter, compared to analyst estimates of $4.58 billion. During the same quarter in the prior year, the firm posted $0.79 earnings per share. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. Sell-side analysts forecast that Colgate-Palmolive will post 3.1 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Shareholders of record on Friday, April 21st will be paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.55%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.47. The ex-dividend date is Thursday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 88.26%.

Analyst Ratings Changes

Several equities research analysts have commented on CL shares. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $81.00 to $86.00 and gave the stock an “overweight” rating in a research report on Friday, January 13th. TheStreet downgraded shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a research note on Friday, January 27th. Barclays dropped their target price on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 31st. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $80.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, January 30th. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Saturday. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $82.27.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.